Soft tissue tumors of the foot

Anatomy and peculiarities of the foot

The foot combines bones, joints, tendons, ligaments, nerves and vessels in a very small space. The skin and the underlying connective and fatty tissue (soft tissues) protect, absorb shocks and enable pain-free walking. However, tight shoes, pressure peaks and high loads make the region sensitive to swelling, irritation and masses.

• Forefoot: ball area, toes, sesamoid bones - common locations for ganglia, Morton's neuroma or plantar fibromas.
• Metatarsus/back of the foot: tendon sheaths, smaller joints and vessels - this is where ganglia, lipomas or hemangiomas occur.
• Hindfoot/heel: Achilles tendon, plantar fascia - bursitis, plantar fibromatoses and rarely tumors are possible.

The narrow soft tissue compartment on the foot means that even benign masses can be disruptive, chafe or limit footwear. When nerves are involved, burning, stabbing pain often occurs.

What are soft tissue tumors on the foot?

Soft tissue tumors are lumps or masses that arise from non-bony structures. Most of the foot lesions are benign (e.g. ganglion, lipoma, plantar fibroma); malignant soft tissue sarcomas are rare. The distinction is important because therapy and aftercare vary significantly.

• Benign tumors/space-occupying lesions: ganglion (above leg), lipoma (fatty tissue), fibroma/plantar fibroma (Ledderhose disease), hemangioma (vascular change), neuroma (nerve thickening).
• Rare malignant tumors (sarcomas): e.g. E.g. synovial sarcoma, clear cell sarcoma, rhabdomyosarcoma – always to be treated in an interdisciplinary manner.

Not every swelling is a “real” tumor: cysts, bursitis, hematomas or inflammation can produce similar findings. Imaging and, if necessary, tissue samples provide clarity.

Common soft tissue tumors of the foot (benign)

We see the following findings particularly frequently in practice. They are predominantly benign, but can be mechanically disturbing or painful.

• Ganglion (above leg): Cyst filled with joint or tendon sheath fluid, usually on the back of the foot or metatarsophalangeal joints of the toes. Size varies, often tender to pressure in the shoe.
• Lipoma: Soft, movable lump of fatty tissue, rarely painful, annoying when pressure is exerted by footwear.
• Plantar fibroma/plantar fibromatosis (Ledderhose's disease): Tough knots in the area of ​​the plantar fascia, often causing pressure and difficulty walking.
• Hemangioma: Rich in blood vessels, can have a bluish shimmer; sometimes tender, occasionally growth spurts.
• Neuroma (e.g. Morton's neuroma): Thickening of an interdigital nerve between the metatarsal bones, typical burning forefoot pain, numbness.

These changes are not malignant, but may require treatment because of pain, pressure sores, or impaired function.

Warning signs: when to think about a malignant tumor?

Malignant soft tissue sarcomas of the foot are rare, but must be ruled out in certain constellations. An early, structured clarification is crucial.

• Rapid increase in size within a few weeks/months
• Size > 5 cm, deep location (below the fascia), firm consistency
• Pain at rest, pain at night, unclear blood values ​​or general symptoms
• Newly occurring neurological deficits (numbness, weakness)
• Previous operations/biopsies without a clear diagnosis and persistent lesion

If sarcoma is suspected, further diagnostics and therapy are carried out in cooperation with a certified sarcoma center in Hamburg. Untargeted, premature excision should be avoided as it may complicate oncological treatment.

Typical symptoms

• Palpable lump or visible swelling
• Pressure pain in the shoe, friction, blistering
• Stress- or movement-dependent pain
• Burning, stinging, electrifying sensations (if nerves are involved)
• Occasionally, numbness or weakness in the affected area

Some lesions remain asymptomatic for a long time and are only noticed by chance. Others cause symptoms early on, for example when exercising or walking for long periods of time.

Causes and risk factors

The development of benign soft tissue tumors is usually multifactorial. Mechanical stimuli, microtrauma or inflammatory processes can promote cysts or fibrotic nodules. Genetic factors play a role in fibromatosis. Malignant tumors arise independently and are rare overall.

• Repetitive strain, tight shoes, pressure peaks
• Tendon sheath and joint irritation (ganglia)
• Fibromatosis (plantar fibroma) with a genetic component
• Vascular abnormalities (hemangiomas)
• Rare: previous operations, scar tissue, foreign body reaction

Diagnostics: This is how we proceed

MRI is the most sensitive method for assessing soft tissue lesions in the foot. It helps to distinguish cysts from solid tumors, to assess the location of nerves/vessels and to plan further action.

If there is reasonable suspicion of malignancy, we coordinate further clarification on an interdisciplinary basis. The aim is to achieve a reliable diagnosis with as few interventions as necessary.

Differential diagnoses: What can look similar?

• Bursitis (inflammation of the bursa), especially heel/forefoot
• Hematoma after trauma, seroma
• Foreign body granuloma (e.g. thorn, glass), infection
• Gout/crystal deposits, rheumatic nodules
• Plantar fasciitis without nodule formation, heel spurs

A clear distinction is important because conservative measures are often sufficient for inflammatory causes, while real masses require other strategies.

Conservative treatment: Gentle at first

Many benign soft tissue tumors do not require surgery. Treatment depends on the symptoms, size, location and everyday impairment. The aim is to reduce pain, relieve pressure and improve function.

• Shoe fitting: Soft upper material, sufficient toe box, avoid pressure points.
• Insoles/padding: pressure redistribution and relief of the affected region.
• Physiotherapy: mobilization, walking technique, stretching and strengthening programs, fascia care (especially for plantar fibromatosis).
• Medication: Short-term anti-inflammatory painkillers if necessary (after consulting a doctor).
• Puncture/Relief: Ultrasound-assisted puncture with/without sclerotherapy can be considered for selected ganglia; Pay attention to relapse rate.

The progress is checked at regular intervals. Increasing size or discomfort may bring a surgical option into play.

Operational Options: Indexed and planned

Surgery is considered if conservative measures are not sufficient, if functional limitations persist or if the diagnosis is unclear. The procedure depends strictly on the type of lesion and its location in the foot.

• Excision of benign tumors: E.g. removal of ganglia, disturbing lipomas or plantar fibromas using a tissue-sparing technique.
• Neuroma therapy: Depending on the findings, neurectomy procedures or relieving measures.
• Hemangiomas: Selective removal of small, superficial lesions; In the case of deeper changes, interdisciplinary consideration is often required.
• Operation planning: protection of nerves/vessels, accesses that are as small as possible, precise pre-planning using imaging.

In the case of lesions that are suspicious for malignancy, the following applies: no untargeted “test excision”. The biopsy and definitive resection should be carried out in oncologically experienced hands and according to standardized planning.

After the procedure, wound rest, elevation and appropriate load control are important in order to avoid swelling and wound healing problems - which are comparatively common in the foot.

If there is a soft tissue sarcoma

Soft tissue sarcomas of the foot are rare but require a standardized, interdisciplinary approach. What is crucial is a correct biopsy, complete resection with sufficient safety margin and – depending on the tumor type, size and location – additional radiation or systemic therapy.

• Therapy planning in the tumor board of a certified sarcoma center
• Imaging staging diagnostics (e.g. MRI, CT) depending on the question
• Oncologically correct incision and reconstruction to preserve function
• Structured aftercare with regular checks

We coordinate the necessary steps in Hamburg and accompany you throughout the process. Setting the course early improves functional and oncological results.

Aftercare, rehabilitation and relapse prevention

After conservative or surgical treatment, structured follow-up care is important. In the foot, the focus is on wound healing, swelling management and adapting activity and footwear.

• Wound checks and sutures at intervals, observation for signs of infection
• Elevation, cooling and moderate lymphatic management
• Gradual build-up of load, early mobilization in a low-pain setting
• Physiotherapy: gait, stretches, fascia and scar care
• Insoles/shoe advice on pressure redistribution
• For fibromatous diseases: Prevention of recurrence through adjusted loading, regular self-monitoring

Controls are determined individually. In the case of sarcomas, a separate aftercare plan is carried out according to oncological standards.

Everyday life, sport and prevention tips

• Choose shoes with sufficient toe room and soft upper materials.
• Relieve pressure points with padding/inserts; Vary shoes to avoid pressure spikes.
• increase activity in a measured manner; Use complaints as a signal to adapt to stress.
• Regular self-monitoring: Document size, shape and pain behavior.
• If you have a new, rapidly growing lump, seek medical attention as soon as possible.

There is no targeted prevention against all soft tissue tumors. Early recognition of changes and pressure-relieving measures help to keep symptoms to a minimum.

Your orthopedic contact point in Hamburg

In our practice at Dorotheenstrasse 48, 22301 Hamburg (Winterhude), we advise you on swelling and knots on the foot in a differentiated manner and without unnecessary interventions. We prioritize conservative strategies and clarify transparently when an interventional or surgical measure makes sense. If a malignant lesion is suspected, we coordinate further investigation in cooperation with a certified sarcoma center.